Transaction Data Systems and Outcomes™ Merge to Revolutionize Pharmacy Solutions

Transaction Data Systems (TDS) has announced the completion of its merger with Outcomes™, marking a significant milestone for both companies and the pharmacy industry as a whole. The merger combines TDS's expertise in patient engagement, clinical solutions, and pharmacy workflow with Outcomes' digital capabilities for medication therapy management, patient engagement, and financial insights. The resulting company, which will assume the name Outcomes, aims to offer a comprehensive suite of solutions to the nation's largest network of retail, chain, and grocery pharmacies.

The merger brings together two industry leaders with a shared commitment to improving the health of communities through pharmacy excellence. With over 45 years of combined experience, TDS and Outcomes are well-positioned to deliver unique value-added solutions and establish themselves as the largest provider in the pharmacy market. The newly combined network will bridge care connections with payers and pharmaceutical companies to enhance health outcomes.

Jude Dieterman, Chief Executive Officer of TDS, will continue to serve as CEO of the merged organization, while Brent Stutz, Outcomes' general manager, will become President of the combined company. Cardinal Health, a key player in the pharmaceutical industry, will hold a minority stake in the company, and Debbie Weitzman, Cardinal Health's Chief Executive Officer of its pharmaceutical segment, will join the board of directors.

The merger with Outcomes creates a broad, integrated offering of pharmacy workflow software that serves the patient, pharmacy, payer, and pharmaceutical company ecosystem. TDS's portfolio of clinical pharmacy solutions, including the Rx30 and Computer-Rx pharmacy management systems and PrescribeWellness, will complement Outcomes' digital capabilities. This integration will enable greater operational and workflow efficiency for pharmacy-delivered care across the combined nationwide network of 48,000 retail, chain, and grocery pharmacy locations.

Both TDS and Outcomes have a shared focus on enhancing the delivery of clinical care in the pharmacy setting and enabling diversified revenue streams. The merger provides an exciting opportunity for pharmacists to operate at the top of their license as trusted community healthcare providers.

The mission of Outcomes is rooted in the power of pharmacy to improve patient care outcomes. By uniting technology and clinical relationships through a connected healthcare network, Outcomes aims to drive better health outcomes. The company brings together pharmacies, payers, and pharmaceutical manufacturers to collectively reduce the total cost of care, drive positive patient behavior change, and streamline workflows for pharmacies.

Transaction Data Systems has been dedicated to the success of the pharmacy market and pharmacy supply chain for over 45 years. With its innovative patient-centric technology solutions and pharmacy management systems, such as Rx30, Computer-Rx, and PrescribeWellness, TDS supports one of the largest install bases of independent pharmacies in the industry. TDS is a leading provider of pharmacy-focused, patient-centric solutions that empower pharmacies to deliver exceptional care.

Outcomes™ is committed to improving health outcomes by leveraging technology and clinical relationships. Through its connected healthcare network, Outcomes brings together pharmacies, payers, and pharmaceutical manufacturers to reduce the total cost of care, drive positive patient behavior change, and streamline workflows for pharmacies. With a focus on better health outcomes, Outcomes is revolutionizing the pharmacy industry.

The merger between TDS and Outcomes was facilitated by BlackRock Long Term Private Capital (LTPC) and GTCR. BlackRock LTPC is an innovative private equity strategy that invests in high-quality businesses to create value through active collaboration with management teams. GTCR is a leading private equity firm with expertise in partnering with management leaders to build market-leading companies. The merger represents a transformative growth opportunity for both TDS and Outcomes.

In conclusion, the merger between Transaction Data Systems and Outcomes is poised to revolutionize the pharmacy industry. By combining their expertise and capabilities, the merged company will offer a comprehensive suite of solutions to improve patient care outcomes. With a focus on patient engagement, clinical excellence, and pharmacy workflow efficiency, TDS and Outcomes are set to make a significant impact on the healthcare landscape.